|
|
Regulation Market Research Reports
 | |  |
| |
We offer market research, industry forecasts, and business analysis in the Regulation Market as well as other vertical industries. GII sells reports, databases, newsletters and annual information services that provide the latest market data, such as industry forecasts, projections, trends, market shares, research and development, sales and marketing strategies, and competitive analysis. The easiest way to find out if we have the information you need is to contact us right now. We are open 24 hours a day, 5 days a week with multiple language support. Please see our Contact page to see which office is open right now.
|
|
 | |  |
| Emerging Markets Series: Indonesia and Philippines |
|
| Table of Contents Published: 2009/10 Published by: Datamonitor |
| As the developed markets are becoming increasingly mature, Pharma is turning to the emerging markets, where long-term growth can be sustained. Of particular interest are Indonesia and the Philippines, which are currently going through major reforms to exp ... |
| Booming Clinical Trials Market in India |
|
| Table of Contents Published: 2009/09 Published by: RNCOS E-Services Pvt. Ltd. |
| This report provides extensive information on the clinical trial market in India, with detailed description of the regulatory environment and cost factors promoting the market. It also highlights several emerging market trends like clinical data managemen ... |
| The Pharmaceutical Market: South Korea |
|
| Table of Contents Published: 2009/09 Published by: Espicom Business Intelligence |
| Espicom' s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. ... |
| Chinese Pharmaceutical Market Outlook 2009-2024 |
|
| Table of Contents Published: 2009/08 Published by: Visiongain |
| This report - Chinese Pharmaceutical Market Outlook 2009-2024 - analyses prospects for the pharma market and industry sector in China. This new study discusses market drivers and restraints such as production capacity, intellectual property rights and the ... |
| Oman Pharmaceuticals and Healthcare Report Q4 2009 |
|
| Table of Contents Published: 2009/08 Published by: Business Monitor International |
| In the Q409 BMI's Business Environment Ranking (BER) matrix for Middle East and Africa
(MEA), Oman is placed seventh, having improved its position by three places in relation to the
previous quarter. ... |
| Nigeria Pharmaceuticals and Healthcare Report Q4 2009 |
|
| Table of Contents Published: 2009/08 Published by: Business Monitor International |
| For BMI's Q409 Nigeria Pharmaceutical and Healthcare report, we expect total drug market spending in
the country to rise from US$633mn in 2008 to US$695mn by 2013, representing a compound annual
growth rate (CAGR) of 1.59% in US dollar terms and 3.24% i ... |
| Bangladesh Pharmaceuticals and Healthcare Report Q4 2009 |
|
| Table of Contents Published: 2009/08 Published by: Business Monitor International |
| Of the 15 key markets surveyed in BMI's Pharmaceuticals & Healthcare Business Environment
Rankings, Bangladesh is placed in 14th position, and can be found above Vietnam, the latter being judged
the least attractive proposition for investment. ... |
| The Executive Guide to Worldwide Healthcare Organisation |
|
| Table of Contents Published: 2009/08 Published by: Espicom Business Intelligence |
| Barack Obama' s plans for healthcare reform in the US have generated a great deal of controversy, with opponents appalled at what they see as an increasing tax burden and over involvement of the state. In contrast, the UK' s NHS provides a comprehensive s ... |
| Russia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 ? most notably
as the ruble's managed devaluation earlier in the year did not turn into a rout for the currency, or consume
all of the country's stability fund. Still ... |
| China Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| For the Q309 update of BMI's China Pharmaceuticals & Healthcare report, we have maintained our topline
forecast for medicine expenditure in the world's most populous country, as no new sales figures have
emerged and the country's macroeconomic projectio ... |
| The SADC Healthcare Regulatory Environment |
|
| Table of Contents Published: 2009/07 Published by: Frost & Sullivan |
| This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ... |
| Spain Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| Spainfs pharmaceutical market, valued at EUR15.3bn in 2008, is expected to be cushioned from the
impact of the global financial crisis in the short term, with BMI forecasting nominal drug market
expenditure growth of 6% in euros between 2008 and 2009. ... |
|
| E7: The Outlook for Pharmaceuticals |
|
| Table of Contents Published by: Espicom Business Intelligence |
| The E7 economies have widely differing healthcare systems and priorities, making a detailed knowledge of the background to the market essential for strategic assessment. E7: The Outlook for Pharmaceuticals provides an individual and highly-detailed analys ... |
| The Outlook for Pharmaceuticals in Western Europe |
|
| Published by: Espicom Business Intelligence |
| The Outlook for Pharmaceutical Markets in Western Europe is a unique collection of management reports from Espicom Business Intelligence. Each report provides individual and highly-detailed analysis of each market, looking at the key regulatory, political ... |
|
|
|
View Cart
